Home/Mirvie/Thomas McElrath, M.D., Ph.D.
TM

Thomas McElrath, M.D., Ph.D.

Vice President of Clinical Development

Mirvie

Mirvie Pipeline

DrugIndicationPhase
Encompass TestPreeclampsia Risk PredictionClinical Validation
RNA PlatformSpontaneous Preterm Birth PredictionClinical Validation